US to open embassy in Solomon Islands to counter China’s influence The State Department said Solomon Islanders cherished their history with Americans on the battlefields of World War II Wales Online · Feb 12, 2022
China’s move to amass troops along LAC was violation of written commitments: Jaishankar External Affairs Minister’s remarks come after meeting with Australian counterpart. The Hindu · Feb 12, 2022
Mainland China to help overwhelmed Hong Kong with COVID fight China will help Hong Kong to cope with an expanding COVID-19 outbreak by providing testing, treatment and quarantine capacity, Chief Secretary John Lee said on Saturday, adding that there were no plans for a mainland-style lockdown for now. Reuters · Feb 12, 2022
Criticizing Quad doesn't make it less credible, says Jaishankar Giving a fitting response to China's criticism of Quad, External Affairs Minister S Jaishankar on Friday said the group's record and stance on its positive agenda is fairly clear, and criticizing it repeatedly doesn't make it less credible. Dynamite News · Feb 12, 2022
Winter Olympics 2022 day eight: skeleton, women’s curling and more – as it happened Updates from day eight of the winter Games as Jaclyn Narracott took Australia’s first ever medal in skeleton The Guardian - UK · Feb 12, 2022
China says not granting passport renewals for non-essential travel China's National Immigration Administration said it will not be renewing passports for non-essential travel while the international COVID-19 epidemic situation is still severe and cross border travel poses "great security risks". Reuters · Feb 12, 2022
China approves Pfizer Covid pill China has granted emergency approval for a Pfizer Covid-19 pill in a promising sign that the country could open up further to foreign vaccines and treatments for the virus. Bangkok Post · Feb 12, 2022
U.S. plans Solomon Islands embassy in push to counter China The United States will open an embassy in the Solomon Islands, Secretary of State Antony Blinken said on Saturday as he committed more diplomatic and security resources into the Pacific as a counter to China's drive for greater influence. Reuters · Feb 12, 2022
China grants approval for Pfizer’s antiviral COVID pill China granted emergency approval for Pfizer’s COVID-19 pill in a promising sign the country could open up further to foreign vaccines and treatments for the virus. Tribune News Service · Feb 12, 2022
Behind China-South Korea skating row, a deeper cultural rift Chinese and South Korean short track ice skating fans are duking it out online over allegations of foul play, tapping into the historical rivalry between their countries The Independent UK · Feb 12, 2022
China reports 99 new COVID-19 cases on Feb 11 vs 101 a day earlier China reported 99 new confirmed coronavirus cases on Feb. 11, down from 101 a day earlier, its health authority said on Saturday. Reuters · Feb 12, 2022
US aims to counter China by opening Solomon Islands embassy The U_S_ says it will open an embassy in the Solomon Islands, laying out in unusually blunt terms a plan to increase its influence in the South Pacific nation before China becomes “strongly embedded.” The Independent UK · Feb 12, 2022
BEIJING DIARY: A taste of Tibet with Chinese characteristics People attending the Beijing Winter Olympics can't visit Tibet because they're in China's “closed loop" system for foreign visitors The Independent UK · Feb 12, 2022
Biden's Indo-Pacific strategy homes in on China's "sphere of influence" The Biden administration warns that there is only a narrow window of time remaining to prevent China from transforming the region into its own sphere of influence. Axios · Feb 11, 2022
The Hindu · Feb 11, 2022 Collective action key to new U.S. Indo-Pacific strategy Washington will ‘continue to support India’s rise and regional leadership’, says document
Reuters · Feb 11, 2022 U.S. vows stepped up Indo-Pacific effort in push back against China The United States vowed on Friday to commit more diplomatic and security resources to the Indo-Pacific to push back against what its sees as China's bid to create a regional sphere of influence and become the world's most influential power.
The Independent UK · Feb 11, 2022 US strategy for Indo-Pacific stresses alliances on China A new Biden administration strategy for the Indo-Pacific emphasizes not going it alone in dealing with China's rising influence
Benzinga · Feb 11, 2022 FDA AdComm Votes Against Lilly's Lung Cancer Drug, Sintilimab The FDA advisory committee voted against the full approval of Eli Lilly And Co's (NYSE: LLY) lung cancer treatment over concerns that the clinical trial was conducted only in China and that its results did not apply to U.S. patients.
The Guardian - AU · Feb 11, 2022 At the prospect of ending a decade of climate bollocks, the PM donned a dusty Abbott onesie and zipped up The desperation on show during this past parliamentary week tells us we’ve entered the ‘whatever it takes’ zone of pre-campaign campaigning
The Independent UK · Feb 11, 2022 Eileen Gu’s Instagram comment causes fury in China ‘Why can you use Instagram and millions of Chinese people from the mainland cannot,’ asked one social media user
Al Jazeera · Feb 11, 2022 China continues its labour abuse practices against Uighurs: UN A new UN report details a ‘widespread and systematic programme’ of abuse in Xinjiang as well as China’s vehement denial.
Evening Standard · Feb 11, 2022 Boris Johnson pushing to restart China trade talks sparking fury among Conservative MPs ‘If this government decides that they are going to kowtow to China by going over there and begging them to trade I have to tell you that they can think again,’ Iain Duncan Smith said
The Independent UK · Feb 11, 2022 Countries ask to join WTO talks over China, Lithuania spat More countries have asked this week to join talks about the European Union’s complaint with the World Trade Organization accusing China of exerting economic pressure on Lithuania
Benzinga · Feb 11, 2022 Gogox Trucks Ahead with Hong Kong IPO Despite Growing Headwinds Key takeaways: Gogox has been approved to list in Hong Kong despite operating in the red for years and seeing no potential profits for at least the next two years Company derives lion’s share of its revenue from mainland China, but may be losing ground to a new rival operated…